Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer
Public ClinicalTrials.gov record NCT00061815. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized Multicenter Study of Cetuximab, Oxaliplatin, 5-Fluorouracil, and Leucovorin vs. Oxaliplatin, 5-Fluorouracil, and Leucovorin in Subjects With Previously Treated Metastatic, EGFR-Positive Colorectal Carcinoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare overall survival in patients with previously-treated metastatic, epidermal growth factor receptor (EGFR)-positive colorectal cancer treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX4) and cetuximab with FOLFOX4 alone.
Study identification
- NCT ID
- NCT00061815
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 102 participants
Conditions and interventions
Conditions
Interventions
- cetuximab Biological
- oxaliplatin Drug
- leucovorin Drug
- 5-fluorouracil Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2003 (Type not available)
- Primary completion
- Dec 2004 (Actual)
- Completion
- Nov 2005 (Actual)
- Last update posted
- Apr 12, 2010
2003 – 2005
United States locations
- U.S. sites
- 39
- U.S. states
- 19
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ImClone Investigational Site | Little Rock | Arkansas | 72205 | — |
| ImClone Investigational Site | Springdale | Arkansas | 72764 | — |
| ImClone Investigational Site | Fountain Valley | California | 92708 | — |
| ImClone Investigational Site | Gilroy | California | 95020 | — |
| ImClone Investigational Site | Greenbrae | California | 94904 | — |
| ImClone Investigational Site | Orange | California | 92868 | — |
| ImClone Investigational Site | Pomona | California | 91767 | — |
| ImClone Investigational Site | San Diego | California | 92120 | — |
| ImClone Investigational Site | Vista | California | 92083 | — |
| ImClone Investigational Site | Hartford | Connecticut | 06105 | — |
| ImClone Investigational Site | Norwalk | Connecticut | 06856 | — |
| ImClone Investigational Site | Stamford | Connecticut | 06902 | — |
| ImClone Investigational Site | Waterbury | Connecticut | 06708 | — |
| ImClone Investigational Site | Boynton Beach | Florida | 33435 | — |
| ImClone Investigational Site | Jacksonville | Florida | 32207 | — |
| ImClone Investigational Site | Leesburg | Florida | 34748 | — |
| ImClone Investigational Site | Orlando | Florida | 32804 | — |
| ImClone Investigational Site | Tampa | Florida | 33613 | — |
| ImClone Investigational Site | Atlanta | Georgia | 30309 | — |
| ImClone Investigational Site | Macon | Georgia | 31201 | — |
| ImClone Investigational Site | Louisville | Kentucky | 40202 | — |
| ImClone Investigational Site | Baton Rouge | Louisiana | 70809 | — |
| ImClone Investigational Site | Baltimore | Maryland | 21225 | — |
| ImClone Investigational Site | Clinton | Maryland | 20735 | — |
| ImClone Investigational Site | Saint Joseph | Michigan | 49085 | — |
| ImClone Investigational Site | Kansas City | Missouri | 64131 | — |
| ImClone Investigational Site | Rolla | Missouri | 65401 | — |
| ImClone Investigational Site | Hackensack | New Jersey | 07601 | — |
| ImClone Investigational Site | Armonk | New York | 10504 | — |
| ImClone Investigational Site | Brooklyn | New York | 11235 | — |
| ImClone Investigational Site | East Setauket | New York | 11733 | — |
| ImClone Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| ImClone Investigational Site | Bismarck | North Dakota | 58501 | — |
| ImClone Investigational Site | Philadelphia | Pennsylvania | 19107 | — |
| ImClone Investigational Site | Charleston | South Carolina | 29406 | — |
| ImClone Investigational Site | Knoxville | Tennessee | 37920 | — |
| ImClone Investigational Site | Nashville | Tennessee | 37203 | — |
| ImClone Investigational Site | Ogden | Utah | 84403 | — |
| ImClone Investigational Site | Richmond | Virginia | 23230 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00061815, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 12, 2010 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00061815 live on ClinicalTrials.gov.